A brief editorial with a clear message on the importance of genomics in tailoring aortic surgery to individual patients' long-term outlook.in bicuspid aortic valve disease in the absence of arch dilatation
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Commentary: Aortic replacement for bicuspid aortic valve disease—How much is too much (or too little)?
March 9, 2021
September 30, 2020
Dr David and colleagues reported the long-term outcomes of aortic valve reimplantation in 465 patients between 1989 and 2018. Clinical and echocardiographic follow-up was available in 98% for a mean duration of 10 ± 6 years.
August 1, 2020
This JANS Note is an editorial in response to a recent publication by Deharo et al comparing TAVR valve-in-valve versus redo-SAVR demonstrating improved short-term outcomes with TAVR ViV. The detail limitations of this study and provide a persuasive argument for the need of a randomized trial comparing both modalities.
Biomechanics of Aortic Dissection: A Comparison of Aortas Associated With Bicuspid and Tricuspid Aortic Valves
July 31, 2020
Aneurysmal ascending aortas were collected from elective aortic surgery, and normal aortas from transplant donors, and dissected aortas from surgery for aortic dissection. These aortas underwent delamination testing in simulation of aortic dissection.
Reoperation After Transcatheter Aortic Valve Replacement: An Analysis of the Society of Thoracic Surgeons Database
June 11, 2020
As TAVR is used in progressively lower-risk cohorts, management of device failure will become increasingly important. This study reports the largest series of patients receiving a surgical reoperation after transcatheter aortic valve replacement (TAVR) using the STS Adult Cardiac Surgery Database.
February 3, 2020
Use of a novel decision aid for patients with symptomatic aortic stenosis resulted in greater patient knowledge and satisfaction, although decisional conflict was unchanged. Physicians, on the other hand, felt that the aid was not understood by elderly patients, and believed that they used shared decision-making in their usual practice, without the
January 8, 2020
A medium size RCT with encouraging surgical outcomes in the era of TAVI expansion.....
November 22, 2019
Puzzling subgroup from the GALILEO trial, which appears in the same issue of the periodical as an article that discredits the use of rivaroxaban as thromboprevention strategy :
August 13, 2019
A most educative cross-Atlantic retrospective study on an always important question. The short accompanying video is also valuable!
August 11, 2019
Colleagues from Italy and Germany compared the short- and mid-term outcomes of the straight tube graft (David-I) and the Valsalva graft in 232 patients undergoing an isolated David procedure. The two groups did not differ significantly in 30-day mortality (1% vs 2%), late survival (p = 0.799), or valve-related reoperation (p = 0.241).